Stay updated on Pembrolizumab in RCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in RCC Clinical Trial page.

Latest updates to the Pembrolizumab in RCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has removed detailed information about a clinical trial for pembrolizumab in renal cell carcinoma, including study purpose, cohorts, and inclusion/exclusion criteria, while adding a new identifier and a revision number.SummaryDifference25%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference1%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in RCC Clinical Trial page.